Voluntarily Files for Chapter 11 Restructuring Strategic Alternatives Process Continues with Interest from Parties Gritstone bio, Inc. (Nasdaq: GRTS) (“Gritstone” or the “Company”), a...
-- Preliminary randomized Phase 2 data suggest GRANITE (personalized neoantigen vaccine) could drive meaningful clinical benefit in front-line metastatic microsatellite-stable colorectal cancer...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0.0322 | 0.0322 | 0.0322 | 0 | 0 | CS |
4 | 0 | 0 | 0.0322 | 0.0322 | 0.0322 | 0 | 0 | CS |
12 | 0 | 0 | 0.0322 | 0.0322 | 0.0322 | 0 | 0 | CS |
26 | -0.6108 | -94.9922239502 | 0.643 | 0.6624 | 0.031 | 8518471 | 0.09166713 | CS |
52 | -2.8378 | -98.8780487805 | 2.87 | 3.1 | 0.031 | 5399147 | 0.3492443 | CS |
156 | -4.9578 | -99.3547094188 | 4.99 | 6.1 | 0.031 | 2615494 | 1.09862569 | CS |
260 | -9.4378 | -99.6599788807 | 9.47 | 34.67 | 0.031 | 1985351 | 3.63695626 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales